Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885609 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction
A NA study of Tooth Discoloration, sponsored by Home Skinovations.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT03885609: Completed NA study of Tooth Discoloration, sponsored by Home Skinovations.
NCT03885609 is a NA study of Tooth Discoloration that has completed, run by Home Skinovations. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03885609, a NA study of Tooth Discoloration, has completed, sponsored by Home Skinovations.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single blind, prospective study aimed to evaluate the safety and efficacy of the Silk'n ToothWave Power Toothbrush for stains reduction and improvement of teeth shade.
Primary Outcome
Extrinsic Stains will be evaluated using the validated Lobene Stain Index (LSI) Stain Intensity score range is between 0 and 3, where: 0 = no stain 1. = light stain 2. = moderate stain 3. = heavy stain The mean stain intensity will be calculated for both the gingival and body regions of the incisor teeth for each subject. Stain Area score rage is between 0 and 3, where: 0 = no stain 1. = stain covering up to one third of region 2. = stain covering up to two thirds of region 3. = stain cov
Conditions Studied
Interventions
- DEVICE ToothWave
- DEVICE powered toothbrush
Study Locations (1)
Indiana
- Salus research - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2019-04-12 |
| Phase | NA |
What the finished NCT03885609 record still lists
NCT03885609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Tooth Discoloration appearing as the primary indexed condition, and to 2 interventions - of which ToothWave is the first listed.
NCT03885609 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03885609 about?
NCT03885609 is a clinical study titled "Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction". This study is a single blind, prospective study aimed to evaluate the safety and efficacy of the Silk'n ToothWave Power Toothbrush for stains reduction and improvement of teeth shade.
What is the current status of trial NCT03885609?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-02-28. Estimated completion is 2019-04-12.
What conditions does trial NCT03885609 study?
This clinical trial studies the following conditions: Tooth Discoloration.
What interventions are being tested in trial NCT03885609?
The interventions under investigation include: ToothWave (DEVICE), powered toothbrush (DEVICE).
Who is sponsoring clinical trial NCT03885609?
This trial is sponsored by Home Skinovations, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03885609 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tooth Discoloration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03885609's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI